ADHD and diabetes drugs to be tested in pioneering Alzheimer’s study - Prime Minister Andy Burnham, whose father Roy died ...
A clinical trial has been launched in the UK which scientists hope could cut years from the search for new treatments for ...
Atomoxetine was chosen for the trial because it targets the chemical noradrenaline, which regulates attention, memory and ...
A first-of-its-kind clinical trial has launched in the UK, which could cut years from the search for treatments that work for ...
After five years of believing she had MS, Christina Applegate learned she’d been misdiagnosed. She’s far from the only star to receive an incorrect diagnosis.
PRNewswire/ -- ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage biotechnology company developing gene therapies ...
Nearly two-thirds of children that were found to have early-stage type 1 diabetes through a screening program in eight European countries had no parent or sibling with the disease ...
A natural compound the body produces after consuming foods such as pomegranates may improve heart function by as much as 80% ...
Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the European Commission (EC) has approved KEYTRUDA ® (pembrolizumab), Merck’s anti-PD-1 therapy, in combination ...
Roche continues strong momentum in the third quarter with sales growth of +7% at constant exchange rates (CER) and +8% in CHF; Group sales increase +6% (CER), +1% in CHF, in the first nine months of ...
A new study led by researchers at the UCLA Health Jonsson Comprehensive Cancer Center found that a nutritional supplement ...
London, UK - 21 October, 2026 - Quell Therapeutics announced today that QEL-005, its CD19 B-cell activated Phenotype-Locked™ engineered nTreg therapy, has advanced to the second planned dose cohort in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results